Correlation Between Virax Biolabs and Biomarin Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Biomarin Pharmaceutical, you can compare the effects of market volatilities on Virax Biolabs and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Biomarin Pharmaceutical.
Diversification Opportunities for Virax Biolabs and Biomarin Pharmaceutical
0.89 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Virax and Biomarin is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Biomarin Pharmaceutical go up and down completely randomly.
Pair Corralation between Virax Biolabs and Biomarin Pharmaceutical
Given the investment horizon of 90 days Virax Biolabs Group is expected to under-perform the Biomarin Pharmaceutical. In addition to that, Virax Biolabs is 4.54 times more volatile than Biomarin Pharmaceutical. It trades about -0.14 of its total potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about -0.28 per unit of volatility. If you would invest 6,998 in Biomarin Pharmaceutical on August 24, 2024 and sell it today you would lose (653.00) from holding Biomarin Pharmaceutical or give up 9.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. Biomarin Pharmaceutical
Performance |
| Timeline |
| Virax Biolabs Group |
| Biomarin Pharmaceutical |
Virax Biolabs and Biomarin Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Biomarin Pharmaceutical
The main advantage of trading using opposite Virax Biolabs and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |